"Clinical Partners is a research site conducting clinical trials in Johnston, Rhode Island on the Atwood Medical Center Campus (New England’s largest free-standing medical facility). With access to over 100 physicians, Clinical Partners conducts the highest quality patient trials so that new, safe and effective medications can be found for various diseases."

During the past decade, Clinical Partners, LLC conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 44 clinical trials were completed, i.e. on average, 104.8% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 27 clinical trials were completed. i.e. 180% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Partners, LLC" #1 sponsor was "Eli Lilly and Company" with 14 trials, followed by "Amgen" with 6 trials sponsored, "Janssen Research & Development, LLC" with 6 trials sponsored, "Pfizer" with 5 trials sponsored and "Boehringer Ingelheim" with 5 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Partners, LLC" #1 collaborator was "Dermira, Inc." with 4 trials as a collaborator, "GlaxoSmithKline" with 3 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Astellas Pharma Europe B.V." with 1 trials as a collaborator and "Hexal AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Partners, LLC" are "Psoriasis" (19 trials), "Atopic Dermatitis" (14 trials), "Acne Vulgaris" (11 trials), "Plaque Psoriasis" (9 trials) and "Dermatitis, Atopic" (2 trials). Many other conditions were trialed in "Clinical Partners, LLC" in a lesser frequency.

Most popular intervention types in "Clinical Partners, LLC" are "Drug" (59 trials), "Biological" (11 trials), "Other" (9 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "Lebrikizumab" (5 trials), "Apremilast" (3 trials), "Guselkumab" (3 trials) and "Ixekizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Partners, LLC" are 68 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Partners, LLC". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 51 completed trials in Clinical Partners, LLC, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Partners, LLC, 1 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".